Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-CZ-104298-5   |   PDF   |   Print   |  
| 
published: 16 Oct 2012 last updated: 26 Feb 2021
General Information
Deliberate release (small-scaled field trial) of genetically modified plum plum cv. Stanley clone C-5 containing the coat protein gene of Plum pox virus
EN
06 Mar 2007
Risk assessment details
Methodology and points to consider
EN
EN
EN
No difference regarding persistence in agricultural habitats or invasiveness in natural habitats compared to conventional plum varieties is expected. Nor is it expected that a selective advantage or disadvantage is conferred to the GM clone via the introduced traits.
Due to the measures to be taken during the release (distance to cultivated and wild relatives) the potential for gene transfer will be diminished. No effects are expected on biogeochemical processes.
See the attachment for details.
EN
The dispersion of a transgene will be diminished by planting of GM plants in space isolation - more than 1 km from any other plant of plum or related species. All fruits will be harvested to prevent spread of transgene. Potential plum seedlings will be monitored and removed.
See the attachment for details.
EN
EN
Czech Republic, Prague
EN
EN
Additional information
The field trial was authorized by the Ministry of the Environment in March 2007. In 2009, the trial was officially extended on request of the consent holder to test 16 more GM plum trees.
In November 2012, the trial was officially prolonged on request of the consent holder till 2017.
EN
Records referencing this document Show in search
Record type Field Record(s)
Country's Decision or any other Communication Risk assessment 1